Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLB II vs QLB III vs PVB in Laparoscopic Cholecystectomy
NCT05943015Completed
- Sponsor
- Gaziosmanpaşa Training and Research Hospital
- Start
- Sep 2022
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (3 arms), sponsored by Gaziosmanpaşa Training and Research Hospital. Primary endpoint: Total amount of tramadol use at 24 hours. Started Sep 2022; status: completed.
Beyond the preview
Go deeper on NCT05943015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05943015.